TickerFactsScreenerDevelopers

Lipocine Inc. (LPCN) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2011: $8.57M2012: $5.38M2013: $45.26M2014: $27.67M2015: $20.01M2016: $5.56M2017: $3.21M2018: $8.08M2019: $9.73M2020: $19.22M2021: $2.95M2022: $3.15M2023: $4.77M2024: $6.21M2025: $5.21M$5.21M
2011Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$5.21M-16.1%
2024$6.21M+30.1%
2023$4.77M+51.6%
2022$3.15M+6.7%
2021$2.95M-84.6%
2020$19.22M+97.5%
2019$9.73M+20.4%
2018$8.08M+151.6%
2017$3.21M-42.3%
2016$5.56M-72.2%
2015$20.01M-27.7%
2014$27.67M-38.9%
2013$45.26M+741.8%
2012$5.38M-37.2%
2011$8.57M—